154 related articles for article (PubMed ID: 33472951)
1. ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma.
Khanna P; Soh HJ; Chen CH; Saxena R; Amin S; Naughton M; Joslin PN; Moore A; Bakouny Z; O'Callaghan C; Catalano P; Signoretti S; McKay R; Choueiri TK; Bhasin M; Walther T; Bhatt RS
Sci Transl Med; 2021 Jan; 13(577):. PubMed ID: 33472951
[TBL] [Abstract][Full Text] [Related]
2. ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
Singh N; Joshi S; Guo L; Baker MB; Li Y; Castellano RK; Raizada MK; Jarajapu YP
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1697-707. PubMed ID: 26386115
[TBL] [Abstract][Full Text] [Related]
3. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
4. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
5. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
[TBL] [Abstract][Full Text] [Related]
6. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
8. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
9. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
[TBL] [Abstract][Full Text] [Related]
10. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
12. The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
Ye G; Qin Y; Lu X; Xu X; Xu S; Wu C; Wang X; Wang S; Pan D
Biochem Biophys Res Commun; 2015 Mar; 459(1):18-23. PubMed ID: 25701390
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
14. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
15. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S; Kaplan M; Gamliel-Lazarovich A
Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
[TBL] [Abstract][Full Text] [Related]
16. Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent.
Serfozo P; Wysocki J; Gulua G; Schulze A; Ye M; Liu P; Jin J; Bader M; Myöhänen T; García-Horsman JA; Batlle D
Hypertension; 2020 Jan; 75(1):173-182. PubMed ID: 31786979
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).
Bernardi S; Burns WC; Toffoli B; Pickering R; Sakoda M; Tsorotes D; Grixti E; Velkoska E; Burrell LM; Johnston C; Thomas MC; Fabris B; Tikellis C
Clin Sci (Lond); 2012 Jul; 123(1):29-37. PubMed ID: 22288735
[TBL] [Abstract][Full Text] [Related]
18. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
Moreira de Macêdo S; Guimarães TA; Feltenberger JD; Sousa Santos SH
Peptides; 2014 Dec; 62():189-96. PubMed ID: 25453980
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis.
Cao X; Yang F; Shi T; Yuan M; Xin Z; Xie R; Li S; Li H; Yang JK
Sci Rep; 2016 Feb; 6():21592. PubMed ID: 26883384
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]